The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...

People with early-onset Parkinson’s face challenges different from those with traditional late-onset Parkinson’s.

A new study reveals disappointing results on the potential of GLP-1 drugs like Ozempic to treat Parkinson's disease. Despite ...

A compound that showed early promise in the treatment of Parkinson's disease in fruit flies has also shown neuroprotective ...

The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...

The concept of a cognitive reserve is linked to lowering the risk of diseases such as Alzheimer's, Parkinson's, MS or having ...

Researchers concluded that the GLP-1RA showed no ability to slow disease progression in people living with Parkinson’s ...

Supernus Pharmaceuticals has won US approval for its wearable pump Onapgo (apomorphine hydrochloride) to treat symptoms of ...

Richard Balanson says when one suffers a disease "you begin to accumulate friends" who have their own story with the same ...

Ozzy Osbourne has been battling a rare form of Parkinson's Disease known as Parkin 2. In 2020, he disclosed to his fans that ...

The idea originated in the late 1980s, the experts said, when researchers described individuals with no apparent symptoms of ...

Onapgo is a subcutaneous apomorphine infusion device for the treatment of motor fluctuations in patients with advanced disease ...